Skip to main content

Direct-to-Consumer Genetic and CRISPR Technology

From the 2021 Joint Annual Meeting (recorded 6/29/2021)
Presented by Brandy Gunsolus, DCLS, MLS(ASCP)cm

This session will discuss direct-to-consumer (DTC) genetic testing, how these labs are regulated, how accurate results are, and what happens when patients receive DTC genetic results. Information about CRISPR gene editing and its ethical issues will also be presented.

At the conclusion of this presentation, participants will be able to:

  • Describe what Direct-to-Consumer (DTC) genetic testing is and the accuracy of results.
  • Describe what CRISPR is and how it works.
  • Identify and discuss ethical issues with both DTC and CRISPR.

ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of General will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

This Intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.